Lewis R. Canning

Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

R.D. Neirinckx, Lewis R. Canning, I. M. PIPER et al. · PubMed · 1987 · 498 citations

Engineering, Pet-mri, Spect Imaging +28

Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging

David P. Nowotnik, Lewis R. Canning, S. A. CUMMING et al. · Nuclear Medicine Communications · 1985 · 125 citations

Pet-mri, Cerebral Vascular Regulation, Positron Emission Tomography +20

A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease

Peter J. Ell, J. M.L. HOCKNELL, Peter H. Jarritt et al. · Nuclear Medicine Communications · 1985 · 113 citations

Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO)

Richard A. Holmes, Susan B. Chaplin, K. G. ROYSTON et al. · Nuclear Medicine Communications · 1985 · 105 citations

Imaging Agent, Pet-mri, Cerebral Vascular Regulation +20

Synthesis, characterization, and x-ray structural determinations of technetium(V)-oxo-tetradentate amine oxime complexes

S.S. Jurisson, E. O. Schlemper, D.E. Troutner et al. · Inorganic Chemistry · 1986 · 98 citations

Inorganic Chemistry, Chemical Engineering, Amine Oxime Complexes +14